Recarb 25 Mg Tablet 10s
MRP: ₹51.00
Packaging
10 TAB
Composition
Acarbose 25mg
Company
Bal Pharma
MRP: ₹51.00
Packaging
10 TAB
Composition
Acarbose 25mg
Company
Bal Pharma
| Medicine | Company | Price | You Save |
|---|---|---|---|
| AC 25mg Tablet 10s | USV | ₹46.00 | Save ₹5.00 |
| Rebose 25mg Tablet 10s | Sun Pharma | ₹57.00 | — |
| Diabose 25 Tablet 10s | Micro Labs | ₹68.50 | — |
| Glucar 25mg Tablet 10s | Glenmark | ₹73.50 | — |
| Glucobay 25 mg Tablet 10s | Bayer (India) | ₹73.70 | — |
Acarbose slows the digestion of carbohydrates in the body, which helps control blood sugar levels. Acarbose is used to treat type 2 diabetes. Acarbose is sometimes used in combination with insulin or other diabetes medications you take by mouth. Acarbose may also be used for purposes not listed in this medication guide.
Flatulence, abdominal pain, distension, diarrhoea, nausea, vomiting. Elevation of transaminases, hepatitis, jaundice. Rarely, skin reactions. Potentially Fatal: Hepatotoxicity.
Drugs that may increase blood glucose levels e.g. thiazides, steroids, chlorpromazine, atypical antipsychotics, may antagonise the action of acarbose. GI adsorbents and digestive enzyme preparations may reduce acarbose effects; avoid concomitant admin. Cholestyramine may enhance effects of acarbose. Effects of other hypoglycaemics may be potentiated by acarbose. Neomycin may enhance reduction of postprandial blood-glucose and intensify GI symptoms. Acarbose may reduce digoxin bioavailability. May interact with warfarin and affect INR. Increased risk of hypoglycaemia with disopyramide.
Patients <18 yr; diabetic ketoacidosis or cirrhosis; malabsorption; inflammatory bowel disease; with or pre-disposed to intestinal obstruction; intestinal diseases that affect digestion or absorption; conditions that worsen as a result of increased gas formation e.g. hernias; colonic ulcers; hepatic impairment; CrClr< 25 ml/min/1.73m2. Pregnancy, lactation.
Acarbose competitively and reversibly inhibits pancreatic α-amylase and intestinal brush border α-glucosidases, resulting in retardation of glucose absorption from hydrolysed complex carbohydrates and reduction of blood-glucose concentrations. Absorption: 35% absorbed from the GI tract (oral). Metabolism: Intestines by microbial flora and intestinal enzymes. Excretion: Via urine and faeces.
Monitor LFT every 3 mth for 1st yr and periodically thereafter especially for doses >50 mg tid. Reduce dose or withdraw therapy if transaminases elevations persist. If hypoglycaemia occurs, give glucose orally as a 1st aid measure. Adhere strictly to the prescribed diabetic diet to avoid intensification of GI symptoms.
Take orally with food and water, as directed by your physician.
Keep in a cool, dry place away from sunlight and moisture.
This content is for educational purposes only. Please consult your doctor before use.
| Brand Name | Form | Price |
|---|---|---|
| Aclotil-75mg Tab | TAB | ₹42.00 |
| Aclotil-75mg Tab | TAB | ₹42.00 |
| Aldostix Tablet 10s | TAB | ₹25.00 |
| Amenova 5mg Tablet 10s | TAB | ₹58.50 |
| Amlotus AT Tablet 10s | TAB | ₹35.00 |
| Aziwin 250mg Tablet 6s | TAB | ₹65.63 |
| Aziwin 500mg Tablet 3s | TAB | ₹73.59 |
| Aziwin Syrup 100mg/5ml | SYRUP | ₹26.80 |
| Aziwin Syrup 200mg/5ml | SYRUP | ₹40.00 |
| Balpod 200mg Tablet 10s | TAB | ₹155.00 |
| Balpod CV Tablet 6s | TAB | ₹150.00 |
| Balvidine Solution 100ml | SOLUTION | ₹40.95 |
| Citrocium Tablet 10s | TAB | ₹30.00 |
| Cortiderm Cream | Cream | ₹0.00 |
| Cortiderm Cream | Cream | ₹0.00 |
Written by: SastiMedic Medical Team
Reviewed by: Registered Pharmacist